• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Analysis of transcriptional regulation of the NO synthase gene in human endothelial cells

Research Project

Project/Area Number 10670666
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Circulatory organs internal medicine
Research InstitutionKochi Medical School

Principal Investigator

MIYAHARA Kaoru  Kochi Medical School, Dept. Medical Chemistry, Research Associate, 医学部, 助手 (30229877)

Project Period (FY) 1998 – 1999
Project Status Completed (Fiscal Year 1999)
Budget Amount *help
¥1,800,000 (Direct Cost: ¥1,800,000)
Fiscal Year 1999: ¥700,000 (Direct Cost: ¥700,000)
Fiscal Year 1998: ¥1,100,000 (Direct Cost: ¥1,100,000)
KeywordsNO synthase / endothelial cells / promoter activity / transcriptional factors / NO合成酵素 / 一酸化窒素 / プロモーター
Research Abstract

In endothelial cells, endothelial nitric oxide synthase(eNOS) catalyzes the conversion of L-arginine to L-citrulline and nitric oxide(NO) to play a role in vasodilatation and inhibition of platelet aggregation. To characterize the regulation of the human eNOS gene expression in endothelial cells, we have analyzed the promoter activity of the 5' flanking region of the eNOS gene. We have shown that a Sp1 -binding consensus motif(- 104 to -96) is essential for a core promoter activity of the eNOS gene. In this report, the proximal region from -108 to - 16 was continuously protected in DNase I footprinting analyses. Pyrimidine-rich and purine-rich strings containing three repeats of CCCCTCC and the Sp1-binding motif were included in the protected region. One or two repeats of CCCCTCC were not enough to bind to make any complexes, but all the three repeats should be required for binding to make several DNA-protein complexes on incubation with nuclear extract from the endothelial cells. Transfection expression analyses with substitution mutations showed that the three repeats also have an effective role in transcriptional activity of the eNOS gene.
Furthermore, HIV Tat activates NF-kapperB and this activation can be attenuated by endogenous or exgenous NO. We demonstrate that the Sp1 motifs and the pyrimidine-rich strings in the NOS gene promoter are required for the induction of the NOS gene expression by Tat.

Report

(3 results)
  • 1999 Annual Research Report   Final Research Report Summary
  • 1998 Annual Research Report
  • Research Products

    (6 results)

All Other

All Publications (6 results)

  • [Publications] 宮原 馨: "内皮型NO合成酵素の発現調節"心血管病態とNO編者 島田和幸・池田康夫ら. 13-22 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Chen,F.et al.: "Nitric oxide inhibits HIV tat-induced NF-kapperB activation"Am.J.Pathol.. 155. 275-284 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Chen, F., Lu, Y., Castranova, V., Rojanasakul, Y., Miyahara, K., Shizuta, Y., Vallyathan, V., Shi, X., and Demers, L. M.: "Nitric oxide inhibits HIV tat-induced NF-kapperB activation."Am. J. Pathol.. 155. 275-284 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] 宮原 馨: "内皮型NO合成酵素の発現調節"心血管病態とNO 編者 島田和幸・池田康夫ら. 13-22 (1998)

    • Related Report
      1999 Annual Research Report
  • [Publications] Chen,F.et al.: "Nitric oxide inhibits HIV tat-induced NF-kapper B activation."Am.J.Pathol.. 155. 275-284 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] 宮原 馨: "内皮型NO合成酵素の発現調節" 心血管病態とNO 編者 島田和幸・池田康夫ら. 13-22 (1998)

    • Related Report
      1998 Annual Research Report

URL: 

Published: 1998-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi